Persistence and failure rates of adalimumab monotherapy in biologic-naïve patients with psoriasis: A retrospective study - 16/02/16
Doi : 10.1016/j.jaad.2015.11.005
Shivani P. Reddy, BS a, Elaine J. Lin, BS b, Vidhi V. Shah, BS c, Jashin J. Wu, MD d, ⁎ 
a University of Illinois at Chicago College of Medicine
b Loma Linda University School of Medicine, Los Angeles, California
c University of Missouri-Kansas City School of Medicine
d Department of Dermatology, Kaiser Permanente Los Angeles Medical Center
∗Correspondence to: Jashin J. Wu, MD, Department of Dermatology, Kaiser Permanente Los Angeles Medical Center, 1515 N Vermont Ave, Fifth Floor, Los Angeles, CA 90027Department of DermatologyKaiser Permanente Los Angeles Medical Center1515 N Vermont Ave, Fifth FloorLos AngelesCA90027
| Funding sources: None. |
|
| Disclosure: Dr Wu received research funding from AbbVie, Amgen, AstraZeneca, Coherus Biosciences, Dermira, Eli Lilly, Janssen, Merck, Novartis, Pfizer, Regeneron, Sandoz, and Sun Pharmaceutical Industries; he is a consultant for AbbVie, Amgen, Celgene, Dermira, Eli Lilly, Pfizer, and Sun Pharmaceutical Industries. Ms Reddy, Ms Lin, and Ms Shah have no conflicts of interest to declare. |
© 2015
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 74 - N° 3
P. 575-577 - mars 2016 Retour au numéro
Article précédent
- Omalizumab in patients with severe and refractory solar urticaria: A phase II multicentric study
- François Aubin, Martine Avenel-Audran, Michel Jeanmougin, Henri Adamski, Jean-Louis Peyron, Marie-Claude Marguery, Fabienne Léonard, Marc Puyraveau, Manuelle Viguier, Société Française de Photodermatologie
- Characteristics and treatment of adult-onset linear morphea: A retrospective cohort study of 61 patients at 3 tertiary care centers
- Daniel R. Mazori, Natalie A. Wright, Mital Patel, Stephanie W. Liu, Sarika M. Ramachandran, Andrew G. Franks, Ruth Ann Vleugels, Alisa N. Femia
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?